Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Schistosoma mansoni | sphingoid long chain base kinase | 0.0778 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0526 | 0.6516 | 0.6516 |
Onchocerca volvulus | Bile acid receptor homolog | 0.0526 | 0.6516 | 1 |
Echinococcus multilocularis | sphingosine kinase 1 | 0.0778 | 1 | 1 |
Mycobacterium ulcerans | hypothetical protein | 0.0778 | 1 | 0.5 |
Brugia malayi | ecdysteroid receptor | 0.0526 | 0.6516 | 1 |
Schistosoma mansoni | sphingosine kinase A B | 0.0778 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0778 | 1 | 1 |
Mycobacterium tuberculosis | Conserved protein | 0.0778 | 1 | 0.5 |
Entamoeba histolytica | hypothetical protein, conserved | 0.0778 | 1 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
MIC (functional) | > 64 ug ml-1 | Antibacterial activity against Escherichia coli ATCC 25922 after 18 hrs by NCCLS agar dilution method | ChEMBL. | 23811087 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.